2022
DOI: 10.1007/s10753-022-01763-5
|View full text |Cite
|
Sign up to set email alerts
|

Hederagenin Suppresses Inflammation and Cartilage Degradation to Ameliorate the Progression of Osteoarthritis: An In vivo and In vitro Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 68 publications
0
8
0
Order By: Relevance
“…Among the bioactive compounds investigated, the mechanism of action of hederagenin has been extensively studied in several studies. In fact, hederagenin has been reported to have anti-tumour and anti-inflammatory effects by regulating the NFκB, PI3K/AKT and JAK2/STAT3/MAPK signalling pathways, and by reducing the expression of pro-inflammatory cytokines or enzyme production, including Tumor Necrosis Factor- α (TNF-α), interleukin 6 (IL-6), NO, prostaglandin E2 (PGE 2 ), inducible nitric oxide synthase (iNOS) and COX-2 ( Zhang et al, 2012 ; Lee et al, 2015 ; Kim et al, 2017 ; Yu et al, 2020 ; Shen et al, 2023 ). Our results indicate the accordance between the molecular docking and the previous studies thereby confirming the efficacy of hederagenin as a prominent lead compound for the management of inflammation and cancer development.…”
Section: Resultsmentioning
confidence: 99%
“…Among the bioactive compounds investigated, the mechanism of action of hederagenin has been extensively studied in several studies. In fact, hederagenin has been reported to have anti-tumour and anti-inflammatory effects by regulating the NFκB, PI3K/AKT and JAK2/STAT3/MAPK signalling pathways, and by reducing the expression of pro-inflammatory cytokines or enzyme production, including Tumor Necrosis Factor- α (TNF-α), interleukin 6 (IL-6), NO, prostaglandin E2 (PGE 2 ), inducible nitric oxide synthase (iNOS) and COX-2 ( Zhang et al, 2012 ; Lee et al, 2015 ; Kim et al, 2017 ; Yu et al, 2020 ; Shen et al, 2023 ). Our results indicate the accordance between the molecular docking and the previous studies thereby confirming the efficacy of hederagenin as a prominent lead compound for the management of inflammation and cancer development.…”
Section: Resultsmentioning
confidence: 99%
“…In an in vitro study, hederagenin exerted chondroprotective and anti-inflammatory effects by suppressing the JAK2/STAT3/MAPK pathway, inhibited extracellular matrix degradation, elevated Aggrecan and Collagen II levels, and reduced levels of MMPs and ADAMTS5. In addition, this pentacyclic triterpenoid saponin inhibited cartilage destruction in rats induced by monosodium iodoacetate [137]. Hederagenin 3-O-(2-O-acetyl)-α-L-arabinopyranoside and the dichloromethane fraction of Dipsaci radix also improved osteoblastic differentiation of human alveolar bone marrow-derived mesenchymal stem cells.…”
Section: Biological Activities Of Dipsacus and Scabiosa Species 61 St...mentioning
confidence: 87%
“…It was found that (6aR,11aR)‐9,10‐dimethoxy‐6a,11a‐dihydro‐6H‐benzofurano[3,2‐c]chromen‐3‐ol can act on tyrosine tRNA synthetase and tryptophanyl tRNA synthetase TrpRS to modulate the biosynthesis of aminoacyl‐tRNA, regulate DNA damage and apoptosis (Chen et al., 2018). Hederagenin has a variety of pharmacological effects such as reversing hyperlipidemia, anti‐depression, anti‐lipid peroxidation, liver protection, and anti‐inflammation (Choi et al., 2001; Gülçin et al., 2006; Lin et al., 2021; Shen et al., 2023; Yamahara et al., 1979; Yang et al., 2022). Notably, hederagenin can play a protective role in blood vessel wall by modulating lipid metabolism disorder and lipid deposition (Lu et al., 2015).…”
Section: Discussionmentioning
confidence: 99%